Is an Ounce of Prevention Worth a Pound of Cure? Comparing Demand for Public Prevention and Treatment Policies

@article{Bosworth2010IsAO,
  title={Is an Ounce of Prevention Worth a Pound of Cure? Comparing Demand for Public Prevention and Treatment Policies},
  author={Ryan C. Bosworth and Trudy Ann Cameron and J. R. Deshazo},
  journal={Medical Decision Making},
  year={2010},
  volume={30},
  pages={E40 - E56}
}
Background. Public policy can affect the allocation of resources between programs designed to prevent illnesses or injuries and programs designed to treat those who are already sick or injured. Information about preferences for treatment and prevention policies can help policy makers more effectively allocate public health resources among alternative uses. Our objective is to assess preferences for publicly funded health policies designed to prevent or treat major health threats. We use… 
Prevention praised, cure preferred: results of between-subjects experimental studies comparing (monetary) appreciation for preventive and curative interventions
TLDR
It appears that people claim to prefer prevention when they are asked to consider other use of resources, but otherwise they prefer treatment, related to perceived urgency.
Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment.
The value of disease prevention vs treatment.
Australian Public Preferences for the Funding of New Health Technologies
TLDR
This study provides reassurance that many criteria routinely used for technology decision making are considered to be relevant by the public and clearly indicate the perceived importance of prevention and early diagnosis.
The Value of Cancer Prevention vs Treatment
TLDR
It is found that the demand value of prevention always exceeds that of treatment and the inverse-S shaped probability weighting found in experimental studies leads to a significant increment in the demand values of both treatment and prevention.
Valuing mortality risk reductions from environmental, transport, and health policies: a global meta-analysis of stated preference studies.
TLDR
This first global meta-analysis of stated preference (SP) surveys of mortality risk valuation finds that mean VSL from studies that pass both scope tests tend to be less sensitive to the magnitude of the risk change, and also tends to decrease when stricter screening criteria are applied.
How do we value a cure?
  • D. Husereau
  • Medicine, Psychology
    Expert review of pharmacoeconomics & outcomes research
  • 2015
TLDR
Given what the authors know about preferences for the funding of prevention and treatment measures, they should expect that cures will not be held to a different measure.
Behavioral economics and regulatory analysis.
  • L. Robinson, J. Hammitt
  • Economics
    Risk analysis : an official publication of the Society for Risk Analysis
  • 2011
TLDR
This article considers three concerns: using estimates of willingness to pay or willingness to accept compensation for valuation, considering the psychological aspects of risk when valuing mortality-risk reductions, and discounting future consequences.
Investigating public values in health care priority – Chileans´ preference for national health care
TLDR
This study shows how a large population sample can participate in major decision making of national health policies, including making a choice of a distributive justice principle, through an original and innovative survey method.
...
1
2
3
4
...

References

SHOWING 1-10 OF 45 REFERENCES
Demand for Public Health-Risk Reduction Policies: The Prevention Survey 1
This document contains a single example of the heavily randomized survey instrument designed to elicit individual preferences over public policies to reduce the risks of major illnesses and injuries.
Assessing Preferences for Prevention versus Treatment Using Willingness to Pay
TLDR
The aggregated WTP responses from the prevention and treatment scenarios presented in this study would imply that treatment is more strongly preferred by society than prevention when the health context is the same and benefits of each are held constant.
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases.
TLDR
This paper presents a discounting model that adequately focuses on the reduction of risk and recognises the potential interpretation of risk reduction for infection as an economic good to be acquired with associated mortality reductions as later indirect effects.
Rationing Decisions and Individual Responsibility for Illness: Are all Lives Equal?
TLDR
Personal responsibility for illness was an important consideration in respondents' rationing allocation decisions and these choices appeared to be stable although possibly influenced by respondents' interpretations of the survey scenarios and decision tasks.
Mortality and Morbidity Risk Reduction : An Empirical Life-cycle Model of Demand with Two Types of Age E ff ects
We develop and test an empirical model of individuals’ intertemporal demands for health risk-mitigation programs over the remaining years of their lives. We estimate this model using data from an
Willingness to Pay and the Valuation of Programmes for the Prevention and Control of Influenza
TLDR
It is shown that the main limitations of the WTP approach are not avoided by adoption of the QALY approach, and WTP provides a broad method of valuation based on individuals’ willingness to trade off a much wider range of commodities.
Determinants of willingness to pay taxes for a community-based prevention programme
TLDR
An interview study of a community-based cardiovascular disease prevention programme in northern Sweden shows that expectations regarding reduced mortality in the community and future savings in public health care spending increase the perceived value of the programme.
...
1
2
3
4
5
...